Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05090618
Other study ID # 1187
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 23, 2021
Est. completion date January 20, 2023

Study information

Verified date March 2023
Source Asfendiyarov Kazakh National Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a GWAS study that aims to identify possible candidate genes associate to heart attack by exploring single nucleotide polymorphism (SNP) in a group of heart attack, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with heart attack


Description:

A genome-wide association study (GWAS) is an approach used in genetics research to associate specific genetic variations with particular diseases. The method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease. Once such genetic markers are identified, they can be used to understand how genes contribute to the disease and develop better prevention and treatment strategies.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date January 20, 2023
Est. primary completion date January 20, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Persons of Kazakh nationality - Age up to 59 years inclusive at the time of primary myocardial infarction - Myocardial infarction was established in accordance with the EOC criteria: An increase and / or decrease in the level of cardiac troponin must be combined with at least one of the following: • Symptoms of myocardial ischemia • Newly occurring ischemic changes on the ECG • The appearance of a pathological Q wave • Identification according to imaging data methods of new areas of non-viable myocardium, or new areas of local contractility disorders of presumably ischemic etiology • Detection of a thrombus in the coronary arteries according to coronary angiography - Presence of coronary angiography - Persons able and willing to provide written informed consent; Exclusion Criteria: - Age at primary myocardial infarction 60 years and older - Heart defects, congenital and acquired - Non-ischemic cardiomyopathies - Autoimmune diseases - Diabetes mellitus at the time of development of primary myocardial infarction - Terminal stages of renal and hepatic failure

Study Design


Related Conditions & MeSH terms


Intervention

Genetic:
DNA analysis
GWAS

Locations

Country Name City State
Kazakhstan Kazakhstan Almaty

Sponsors (1)

Lead Sponsor Collaborator
Asfendiyarov Kazakh National Medical University

Country where clinical trial is conducted

Kazakhstan, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of SNPs associated with Heart Attack Using GWAS to identify candidate genes associate with Heart Attack 1 year
See also
  Status Clinical Trial Phase
Completed NCT04153006 - Comparison of Fingerstick Versus Venous Sample for Troponin I.
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT01467232 - IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Phase 2
Active, not recruiting NCT03561051 - The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
Completed NCT04664881 - Home Telemonitoring In Patients After Myocardial Infarction N/A
Completed NCT03826914 - The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults N/A
Withdrawn NCT04198883 - SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand) Phase 1/Phase 2
Completed NCT03649711 - Chronic Kidney Disease (CKD) Platelet Study Phase 3
Completed NCT03677180 - National Cardiogenic Shock Initiative
Completed NCT05415735 - Stress Management and Resiliency Training Following Acute Myocardial Infarction N/A
Completed NCT02376283 - P3AMI Antiplatelet Trial Phase 4
Completed NCT03654157 - ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow
Completed NCT03252990 - 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability
Recruiting NCT06271577 - Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II N/A
Recruiting NCT06280976 - Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) Phase 4
Completed NCT02581540 - Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin
Recruiting NCT04904107 - Improving the Accuracy of Referrals of Patients With Chest Pain N/A
Completed NCT02032030 - Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
Completed NCT01407146 - Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Withdrawn NCT05957172 - Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation